Champions Oncology, Inc. (CSBR) Q2 2023 Earnings Call Transcript

Dec. 13, 2022 8:54 PM ETChampions Oncology, Inc. (CSBR)
SA Transcripts profile picture
SA Transcripts

Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2023 Earnings Conference Call December 13, 2022 4:30 PM ET

Company Participants

Ronnie Morris - CEO

David Miller - CFO

Conference Call Participants

Scott Henry - ROTH Capital


Good day, ladies and gentlemen, and welcome to the Champions Oncology Second Quarter Fiscal Year 2023 Earnings Call. At this time, all participants have been placed on a listen-only mode and the floor will be opened for you questions and comments after the presentation.

It is now my pleasure to turn the floor over to your host, Dr. Ronnie Morris. Sir, the floor is yours.

Ronnie Morris

Good afternoon. I am Ronnie Morris, CEO of Champions Oncology. Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call.

Before I begin, I will remind you that we will be making forward-looking statements during today's call and that actual results could differ materially from what is described in those statements. Additional information on factors that could cause results to differ is available in our Forms 10-Q and Form 10-K. A reconciliation of non-GAAP financial measures that may be discussed during the call to GAAP financial measures is available in the earnings release.

Overall, we had another good quarter with record revenue in our services business as well as progress in our drug discovery effort. We continue to monitor the current economic environment and for the first time, we have noticed an effect on our business. During this quarter, specifically in September and October, we noticed a slowdown in bookings compared to prior quarters. While the quarter's total bookings remained strong, they were below those obtained in our previous quarter.

Our late-stage pipeline continues to be strong, and we feel that in Q2, there was a general delay when it came

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.